Patents by Inventor Bertrand Bellier

Bertrand Bellier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particles which can be used in the treatment of autoimmune diseases
    Patent number: 11306294
    Abstract: The invention relates to a virus-like particle comprising an autoantigen and an immunoregulatory molecule exposed on its surface. The invention also relates to the use of said particle in the treatment of an autoimmune disease.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: April 19, 2022
    Assignees: Sorbonne Universite, INSERM (Institut National De La Sante Et De La Recherche Medicale), Assistance Publique—Hopitaux De Paris
    Inventors: Bertrand Bellier, David Klatzmann
  • VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES
    Publication number: 20210299195
    Abstract: The invention relates to a virus-like particle comprising an allergen and an immunoregulatory molecule exposed on its surface. The invention also relates to the use of said particle in the treatment of an allergy.
    Type: Application
    Filed: October 28, 2018
    Publication date: September 30, 2021
    Inventors: Bertrand Bellier, David Klatzmann
  • VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20200347363
    Abstract: The invention relates to a virus-like particle comprising an autoantigen and an immunoregulatory molecule exposed on its surface. The invention also relates to the use of said particle in the treatment of an autoimmune disease.
    Type: Application
    Filed: October 26, 2018
    Publication date: November 5, 2020
    Inventors: Bertrand Bellier, David Klatzmann
  • Interleukin-2 for treating food allergy
    Patent number: 10376564
    Abstract: The present invention relates to the use of interleukin-2 (IL-2) for treating a food allergy, either by inducing non-specific tolerance against food allergens, or in a desensitization protocol in combination with a food allergen.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: August 13, 2019
    Assignees: SORBONNE UNIVERSITE, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: David Klatzmann, Bertrand Bellier
  • Synthetic viruses and uses thereof
    Patent number: 9765304
    Abstract: The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: September 19, 2017
    Assignee: L'Universite Pierre Et Marie Curie
    Inventors: David Klatzmann, Jean-Loup Salzmann, Bertrand Bellier, Charlotte Fribert, Francois-Loic Cosset
  • INTERLEUKIN-2 FOR TREATING FOOD ALLERGY
    Publication number: 20170020962
    Abstract: The present invention relates to the use of interleukin-2 (IL-2) for treating a food allergy, either by inducing non-specific tolerance against food allergens, or in a desensitization protocol, in combination with a food allergen.
    Type: Application
    Filed: March 10, 2015
    Publication date: January 26, 2017
    Inventors: DAVID KLATZMANN, BERTRAND BELLIER
  • SYNTHETIC VIRUSES AND USES THEREOF
    Publication number: 20140255445
    Abstract: The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.
    Type: Application
    Filed: January 24, 2014
    Publication date: September 11, 2014
    Applicant: L'Universite Pierre Et Marie Curie
    Inventors: David Klatzmann, Jean-Loup Salzmann, Bertrand Bellier, Charlotte Frisen, Francois-Loic Cosset
  • Synthetic viruses and uses thereof
    Patent number: 8673612
    Abstract: The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: March 18, 2014
    Assignee: L'Universite Pierre et Marie Curie
    Inventors: David Klatzmann, Jean-Loup Salzmann, Bertrand Bellier, Charlotte Frisen, François-Loïc Cosset
  • Synthetic viruses and uses thereof
    Publication number: 20040071661
    Abstract: The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.
    Type: Application
    Filed: October 15, 2003
    Publication date: April 15, 2004
    Inventors: David Klatzmann, Jean-Loup Salzmann, Bertrand Bellier, Charlotte Frisen, Francois-Loic Cosset